Article
Structural insights into ACE2 interactions and immune activation of SARS-CoV-2 and its variants: an in-silico study.
Journal of biomolecular structure & dynamics - 1 Feb 2025
Yousefbeigi Sarina, Marsusi Farah
Abstract excerpt
The initial interaction between COVID-19 and the human body involves the receptor-binding domain (RBD) of the viral spike protein with the angiotensin-converting enzyme 2 (ACE2) receptor. Likewise, the spike protein can engage with immune-related proteins, such as toll-like receptors (TLRs) and pulmonary surfactant proteins A (SP-A) and D (SP-D), thereby triggering immune responses. In this study, we utilize...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
